The application of warm blood cardioplegia for myocardial protection during cardiac surgery in aldult

Doan Duc Hoang , Truong Tuan Anh, Le Nhat Anh, Phan Tai Nhan, Dang Quoc Kha

Main Article Content

Abstract

We retrospectively analyzed, over 14 years (2004-2018), early results of cardiac surgical patients (n=6720) using warm blood cardioplegia for myocardial protection. We access the myocardial cell injury base on research variables collected before surgery, 2h, 8h and 24h postoperatively of cardiac troponin T level, spontaneous defibrillation after removing aortic clamp, use of intra-aortic balloon counter pulsation (IABP), and use of inotropic support, and evaluated cardiac function such as cardiac output measurement, left ventricular ejection fraction as well as the clinical outcome such as ventilation time and ICU stay in these patients. Results: Preoperative demographic and clinical variables with high risk factors were severe heart failure at NYHA.III-IV (81,3%), severe pulmonary artery hypertension (27,7%) and patients undergoing complicated surgery (39,3%) such as multi-valvular surgery or combined valvular and coronary surgery… and long duration in aortic clamp (40,5%) or in cardiopulmonary bypass (40,2%). However, postoperatively, there was a significantly goof progress in cardiac function such as left ventricular ejection fraction (p<0,05), cardiac output (p<0,05) and in clinical outcome such as reduced ventilation time (22,56±30,04 hours) as well as ICU stay (51,16±35,13 hours). 

Article Details

References

[1] Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol 2010;106(3):360e8.
[2] Buckberg GD, Brazier JR, Nelson RL, Goldstein SM, McConnell DH, Cooper N. Studies of the effects of hypothermia on regional myocardial blood flow and metabolism during cardiopulmonary bypass. I. The adequately perfused beating, fibrillating, and arrested heart. J Thorac Cardiovasc Surg 1977;73(1):87e94.
[3] Feng J, Bianchi C, Li J, Sellke FW. Improved profile of bad phosphorylation and caspase 3 activation after blood versus crystalloid cardioplegia. Ann Thorac Surg 2004;77:1384e9.
[4] Fan Y, Zhang A-M, Xiao Y-B, Weng Y-G, Hetzer R. Warm versus cold cardioplegia for heart surgery: a meta-analysis. Eur J Cardiothorac Surg 2010;37(4):912e9.
[5] Fremes SE, Weisel RD, Mickle DA, Ivanov J, Madonik MM, Seawright SJ, et al. Myocardial metabolism and ventricular function following cold potassium cardioplegia. J Thorac Cardiovasc Surg 1985;89(4):531e46.
[6] Brown Jr IW, Smith WW, Emmons WO. An efficient blood heat exchanger for use with extracorporeal circulation. Surgery 1958;44(2):372e7. F.A. Mourad et al. / Journal of the Egyptian Society of Cardio-Thoracic Surgery 24 (2016) 215e222 221.
[7] Calafiore AM, Teodori G, Mezzetti A, Bosco G, Verna AM, Di Giammarco G, et al. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 1995;59(2):398e402.
[8] Fremes SE, Christakis GT, Weisel RD, Mickle DA, Madonik MM, Ivanov J, et al. A clinical trial of blood and crystalloid cardioplegia. J Thorac Cardiovasc Surg 1984;88(5 Pt 1):726e41.
[9] Dar MI. Cold crystalloid versus warm blood cardioplegia for coronary artery bypass surgery. Ann Thorac Cardiovasc Surg 2005;11(6):382e5.
[10] Sirvinskas E, Nasvytis L, Raliene L, Vaskelyte J, Toleikis A, Trumbeckaite S. Myocardial protective effect of warm blood, tepid blood, and cold crystalloid cardioplegia in coronary artery bypass grafting surgery. Croat Med J 2005;46(6):879e88.
[11] Bouchart F. Myocardial revascularization in patients with severe ischemic left ventricular dysfunction. Long term follow-up in 141 patients. Eur J Cardio-Thoracic Surg 2001;20(6):1157e62.
[12] Jacquet LM, Noirhomme PH, Van Dyck MJ, El Khoury GA, Matta AJ, Goenen MJ, et al. Randomized trial of intermittent antegrade warm blood versus cold crystalloid cardioplegia. Ann Thorac Surg 1999;67(2):471e7.

Similar Articles

You may also start an advanced similarity search for this article.